Influenzinum (2020-2021), Herpes Simplex 1 Nosode, Herpes Simplex 2 Nosode, Human Herpesvirus 6A, Human Herpesvirus 6B, Cytomegalovirus Nosode, Hepatitis B Nosode, Adenoviren Nosode, Epstein-Barr Virus Nosode

FDA Drug Profile — Vir Combination

Influenzinum (2020-2021), Herpes Simplex 1 Nosode, Herpes Simplex 2 Nosode, Human Herpesvirus 6A, Human Herpesvirus 6B, Cytomegalovirus Nosode, Hepatitis B Nosode, Adenoviren Nosode, Epstein-Barr Virus Nosode is listed in the FDA National Drug Code directory with 1 NDC code, marketed under brand name including Vir Combination. Available dosage form: liquid.

Drug details

Generic Name
Influenzinum (2020-2021), Herpes Simplex 1 Nosode, Herpes Simplex 2 Nosode, Human Herpesvirus 6A, Human Herpesvirus 6B, Cytomegalovirus Nosode, Hepatitis B Nosode, Adenoviren Nosode, Epstein-Barr Virus Nosode
Brand Names
Vir Combination
Sponsor
Deseret Biologicals, Inc.
NDC Codes
1
Dosage Forms
LIQUID
Routes
ORAL
Active Ingredients
INFLUENZA A VIRUS A/GUANGDONG-MAONAN/SWL1536/2019 CNIC-1909 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/HONG KONG/2671/2019 IVR-208 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/WASHINGTON/02/2019 ANTIGEN (FORMALDEHYDE INACTIVATED), HUMAN HERPESVIRUS 1, HUMAN HERPESVIRUS 2, HUMAN HERPESVIRUS 6, HUMAN HERPESVIRUS 5, HEPATITIS B VIRUS, HUMAN ADENOVIRUS E SEROTYPE 4 STRAIN CL-68578 ANTIGEN, HUMAN ADENOVIRUS B SEROTYPE 7 STRAIN 55142 ANTIGEN, HUMAN HERPESVIRUS 4

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.